Skip to content

MEDMEX: what changed

Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

MEDMEX

BE 0463.428.881
NACE 47.730, Retail sale of pharmaceutical products
financial year 2025 compared with 2024filed annual accounts (NBB)
Net result for the year
€125,987
2024 · €230,147-€104,159
Equity
€684,002
2024 · €558,015+€125,987
Cash
€120,027
2024 · €232,411-€112,384
Balance sheet total
€1.0m
2024 · €1.1m-€76,727

Largest movements

2024 to 2025
Assets
  • Cash -€112,384

    down €112,384 (-48.4%), from €232,411 to €120,027

    mainly Other debts (-€120,000) and Stocks and contracts (-€60,364)

  • Stocks and contracts +€60,364

    up €60,364 (+44.6%), from €135,291 to €195,655

  • Receivables within one year -€22,446

    down €22,446 (-3.0%), from €738,124 to €715,677

    of which Other amounts receivable: -€21,323

Equity and liabilities
  • Profit (loss) carried forward +€125,987

    up €125,987 (+22.9%), from €549,960 to €675,947

  • Other debts -€120,000

    no longer reported in 2025 (was €120,000)

  • Short-term financial debts -€50,499

    down €50,499 (-57.1%), from €88,493 to €37,994

  • Current portion of long-term debt -€46,509

    down €46,509 (-84.3%), from €55,174 to €8,665

  • Trade debts +€21,942

    up €21,942 (+8.3%), from €265,719 to €287,661

Income statement
  • Gross operating margin -€91,415

    down €91,415 (-24.0%), from €380,116 to €288,701

  • Staff costs +€11,053

    up €11,053 (+11.3%), from €98,239 to €109,293

  • Taxes +€4,429

    up €4,429 (+11.2%), from €39,541 to €43,970

From the 2024 result to the 2025 result

effect on the result

Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

Result 2024 €230,147
Gross operating margin -€91,415
Staff costs -€11,053
Depreciation -€373
Other operating charges -€15
Financial charges +€3,126
Taxes -€4,429
Result 2025 €125,987
raises the resultlowers the result

Derived cash bridge

cash 2024 to 2025

Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.

From operations -€2,143
Investment €0
Financing -€110,241
Cash 2024 €232,411
Net result for the year +€125,987
Depreciation +€2,352
Stocks and contracts -€60,364
Receivables within one year +€22,446
Deferred charges and accrued income -€91
Trade debts +€21,942
Tax, wage and social debts +€5,585
Other debts -€120,000
Debts after one year -€13,233
Current portion of long-term debt -€46,509
Short-term financial debts -€50,499
Cash 2025 €120,027
brings cash intakes cash out
Every line side by side 44 lines
Line Code 2024 2025 Change %
Total assets 20/58 €1,110,559 €1,033,832 -€76,727 -6.9%
Fixed assets 21/28 €4,732 €2,381 -€2,352 -49.7%
Tangible fixed assets 22/27 €4,732 €2,381 -€2,352 -49.7%
Plant, machinery and equipment 23 €2,995 €1,410 -€1,584 -52.9%
Furniture and vehicles 24 €1,738 €970 -€767 -44.2%
Current assets 29/58 €1,105,826 €1,031,451 -€74,375 -6.7%
Stocks and contracts in progress 3 €135,291 €195,655 +€60,364 +44.6%
Stocks 30/36 €135,291 €195,655 +€60,364 +44.6%
Amounts receivable within one year 40/41 €738,124 €715,677 -€22,446 -3.0%
Trade receivables 40 €144,988 €143,865 -€1,123 -0.8%
Other amounts receivable 41 €593,136 €571,812 -€21,323 -3.6%
Cash at bank and in hand 54/58 €232,411 €120,027 -€112,384 -48.4%
Deferred charges and accrued income 490/1 - €91 +€91
Total equity and liabilities 10/49 €1,110,559 €1,033,832 -€76,727 -6.9%
Equity 10/15 €558,015 €684,002 +€125,987 +22.6%
Contributions 10/11 €6,200 €6,200 = 0.0%
Reserves 13 €1,855 €1,855 = 0.0%
Non-distributable reserves 130/1 €1,855 €1,855 = 0.0%
Reserves not available under the articles 1311 €1,855 €1,855 = 0.0%
Profit (loss) carried forward 14 €549,960 €675,947 +€125,987 +22.9%
Amounts payable 17/49 €552,544 €349,830 -€202,714 -36.7%
Amounts payable after more than one year 17 €13,233 - -€13,233
Financial debts 170/4 €13,233 - -€13,233
Amounts payable within one year 42/48 €539,311 €349,830 -€189,481 -35.1%
Current portion of amounts payable after more than one year 42 €55,174 €8,665 -€46,509 -84.3%
Financial debts 43 €88,493 €37,994 -€50,499 -57.1%
Credit institutions 430/8 €88,493 €37,994 -€50,499 -57.1%
Trade debts 44 €265,719 €287,661 +€21,942 +8.3%
Suppliers 440/4 €265,719 €287,661 +€21,942 +8.3%
Taxes, remuneration and social security 45 €9,925 €15,510 +€5,585 +56.3%
Taxes 450/3 - €3,970 +€3,970
Remuneration and social security 454/9 €9,925 €11,540 +€1,615 +16.3%
Other amounts payable 47/48 €120,000 - -€120,000
Remuneration, social security and pensions 62 €98,239 €109,293 +€11,053 +11.3%
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets 630 €1,979 €2,352 +€373 +18.9%
Other operating charges 640/8 - €15 +€15
Gross operating margin 9900 €380,116 €288,701 -€91,415 -24.0%
Operating profit (loss) 9901 €279,898 €177,042 -€102,856 -36.7%
Financial charges 65/66B €10,211 €7,085 -€3,126 -30.6%
Recurring financial charges 65 €10,211 €7,085 -€3,126 -30.6%
Profit (loss) for the period before taxes 9903 €269,688 €169,958 -€99,730 -37.0%
Income taxes 67/77 €39,541 €43,970 +€4,429 +11.2%
Profit (loss) for the period 9904 €230,147 €125,987 -€104,159 -45.3%
Profit (loss) for the period to be appropriated 9905 €230,147 €125,987 -€104,159 -45.3%

Source: filed annual accounts (NBB), financial years ended 30 June 2024 and 30 June 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 17 October 2026 via checked.be.